Abstract:Endothelial progenitor cells (EPCs) are a promising cell source for tissue repair and regeneration, predominantly through angiogenesis promotion. Paracrine functions serve a pivotal role in EPC‑mediated angiogenesis, which may be impaired by various cardiovascular risk factors. Therefore, it is important to identify a solution that optimizes the paracrine function of EPCs. Thymosin β4 (Tβ4) is a peptide with the potential to promote tissue regeneration and wound healing. A previous study demonstrated that Tβ4 enhances the EPC‑mediated angiogenesis of the ischemic myocardium. In the present study, whether Tβ4 improved angiogenesis by enhancing the paracrine effects of EPCs was investigated. A tube formation assay was used to assess the effect of angiogenesis, and the paracrine effects were measured using an ELISA kit. The results indicated that Tβ4 improved the paracrine effects of EPCs, evidenced by an increase in the expression of vascular endothelial growth factor (VEGF). EPC‑conditioned medium (EPC‑CM) significantly promoted human umbilical vein endothelial cell angiogenesis in vitro, which was further enhanced by pretreatment with Tβ4. The effect of Tβ4 pretreated EPC‑CM on angiogenesis was abolished by VEGF neutralizing antibody in vitro, indicating that increased VEGF secretion had a pivotal role in Tβ4‑mediated EPC angiogenesis. Furthermore, transplantation of EPCs pretreated with Tβ4 into infarcted rat hearts resulted in significantly higher VEGF expression in the border zone, compared with EPC transplantation alone. To further investigate whether the Akt/eNOS pathway was involved in Tβ4‑induced VEGF secretion in EPCs, the expression levels of VEGF in EPC‑CM were significantly decreased following knockdown of Akt or eNOS by small interfering RNA transfection. In conclusion, Tβ4 significantly increased angiogenesis by enhancing the paracrine effects of EPCs, evidenced by the increased expression of VEGF. The RAC‑α serine/threonine‑protein kinase/endothelial nitric oxide synthase signal transduction pathway was involved in the regulation of Tβ4‑induced VEGF secretion in EPCs. Further studies are required to investigate the long‑term prognosis of patients with coronary heart disease following Tβ4‑pretreated EPC transplantation.

Thymosin beta4 induces angiogenesis through Notch signaling in endothelial cells

Thymosin Β4 Promotes Endothelial Progenitor Cell Angiogenesis Via a Vascular Endothelial Growth Factor‑dependent Mechanism.

Thymosin Beta 4 Induces Endothelial Progenitor Cell Migration Via Pi3k/Akt/Enos Signal Transduction Pathway

Thymosin Β4 Reduces Senescence of Endothelial Progenitor Cells Via the PI3K/AKT/eNOS Signal Transduction Pathway

Thymosin 4 Promotes Glucose-Impaired Endothelial Progenitor Cell Function Via Akt/Endothelial Nitric Oxide Synthesis Signaling Pathway

Thymosin Beta-4, Actin-Sequestering Protein Regulates Vascular Endothelial Growth Factor Expression via Hypoxia-Inducible Nitric Oxide Production in HeLa Cervical Cancer Cells

Thymosin beta 4 silencing suppresses proliferation and invasion of non-small cell lung cancer cells by repressing Notch1 activation.

Human GPR4 and the Notch Signaling Pathway in Endothelial Cell Tube Formation.

Thymosin β4 activates integrin-linked kinase and decreases endothelial progenitor cells apoptosis under serum deprivation.

Construction of Thymosin Beta 4 Eukaryotic Expression Plasmid and Its Effects on Vascular Endothelial Cells

Thymosin Β4 Promotes the Survival and Angiogenesis of Transplanted Endothelial Progenitor Cells in the Infarcted Myocardium

Thymosin Beta-4 Improves Endothelial Function and Reparative Potency of Diabetic Endothelial Cells Differentiated from Patient Induced Pluripotent Stem Cells

Thymosin Beta 4 Protects Mice from Monocrotaline-Induced Pulmonary Hypertension and Right Ventricular Hypertrophy

Notch regulates the angiogenic response via induction of VEGFR-1

Mechanistic Studies on the Role of TGF-β1 in Angiogenesis Through EndMT.

Thymosin beta 4: A Potential Molecular Target for Tumor Therapy

Differential Regulation of Transforming Growth Factor Β Signaling Pathways by Notch in Human Endothelial Cells

TGF-β1 Activated Hepatic Stellate Cells Induce Angiogenesis of Vascular Endothelial Cells

Blocking of DLL4/Notch Signaling Deregulates Tumor Angiogenesis

TGF-β Signaling and Vascular Morphogenesis

Thrombospondin-4 Ablation Reduces Macrophage Recruitment in Adipose Tissue and Neointima and Suppresses Injury-Induced Restenosis in Mice.